After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$159.39K

Rothblatt Martine A Chairperson & CEO

Transaction date Nov 11, 2026
Public filing date Nov 12, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$595.66 Nov 11, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
271 shares @ $588.16
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000187
Filing cohort

Transactions in this filing

Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$6.76M
Buys / sales
0 / 14
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Nov 11, 2026 $589.31K
United Therapeutics Corp UTHR Sale Nov 11, 2026 $801.48K
United Therapeutics Corp UTHR Exercise Nov 11, 2026 $1.12M
United Therapeutics Corp UTHR Sale Nov 11, 2026 $125.98K
United Therapeutics Corp UTHR Sale Nov 11, 2026 $147.86K
United Therapeutics Corp UTHR Sale Nov 11, 2026 $435.39K
United Therapeutics Corp UTHR Sale Nov 11, 2026 $776.3K
United Therapeutics Corp UTHR Sale Nov 11, 2026 $14.61K
United Therapeutics Corp UTHR Sale Nov 11, 2026 $187.71K
United Therapeutics Corp UTHR Current Sale Nov 11, 2026 $159.39K
United Therapeutics Corp UTHR Sale Nov 11, 2026 $172.04K
United Therapeutics Corp UTHR Sale Nov 11, 2026 $177.68K
United Therapeutics Corp UTHR Sale Nov 11, 2026 $694.63K
United Therapeutics Corp UTHR Sale Nov 11, 2026 $570.42K
United Therapeutics Corp UTHR Sale Nov 11, 2026 $790.08K